Ember AI
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ember AI - overview
Established
2022
Location
San Francisco, CA, US
Primary Industry
Insurance
About
Based in the US, Ember AI offers AI solutions that enhance revenue cycle automation for healthcare organizations, optimizing their operational efficiency across various specialties. Founded in 2022 in San Francisco, US, Ember AI specializes in AI-driven revenue cycle automation solutions for healthcare. Co-founded by Charlene Wang and Warren Wang, the company has raised USD 4. 30 mn through a SEED round, primarily from Nexus Venture Partners and Y Combinator, with a total amount raised amounting to USD 4.
30 mn. The company has engaged in 2 deals, with its most recent deal occurring on December 16, 2025. Ember offers advanced AI-driven revenue cycle automation solutions tailored for healthcare organizations across various specialties, including emergency medicine, cardiology, and primary care. The core product integrates seamlessly with major Electronic Health Record (EHR) and Practice Management System (PMS) platforms, such as Epic and Oracle Cerner, facilitating automation in prior authorization, eligibility verification, and claims submission.
By analyzing existing workflows, Ember's AI evolves to achieve full automation, resulting in significant reductions in full-time equivalent (FTE) hours and denial rates. The company primarily serves health systems, Managed Service Organizations (MSOs), and health plans, with a client base that spans multiple geographical markets, including the United States and other regions with advanced healthcare infrastructure. Ember generates revenue through a subscription-based model that aligns with their AI revenue cycle management (RCM) offerings. Clients typically engage in a partnership framework that includes signing a Business Associate Agreement (BAA) to ensure compliance with HIPAA regulations.
The transactions are structured to provide immediate ROI through a pilot program, which can be launched within 30 days and scaled enterprise-wide thereafter. The pricing structure is designed to deliver measurable outcomes, with focus areas including denials prevention and automated coding. The company's flagship services are supported by ongoing analytics and optimization efforts, further enhancing the value delivered to clients in the healthcare sector. In December 2025, Ember AI raised an undisclosed amount of angel funding led by new investor Yunshi Capital.
The company will use this funding to accelerate the development of its multimodal knowledge platform and strengthen its position in the education and enterprise markets. Ember AI is also targeting expansion into new geographic regions, focusing on areas with strong healthcare infrastructure, to enhance accessibility and support for its innovative solutions.
Current Investors
Nexus Venture Partners, Y Combinator, Yunshi Capital
Primary Industry
Insurance
Sub Industries
Health Insurance, Healthcare IT
Website
www.embercopilot.ai
Verticals
Artificial Intelligence, Cloud Computing, FinTech, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.